These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36340447)

  • 1. Efficacy and Safety of External-beam Radiation Therapy for Unresectable Primary or Local Recurrent Cholangiocarcinoma.
    Murakami T; Aizawa R; Matsuo Y; Hanazawa H; Taura K; Fukuda A; Uza N; Shiokawa M; Kanai M; Hatano E; Seno H; Muto M; Mizowaki T
    Cancer Diagn Progn; 2022; 2(6):634-640. PubMed ID: 36340447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
    Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
    World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.
    Ghafoori AP; Nelson JW; Willett CG; Chino J; Tyler DS; Hurwitz HI; Uronis HE; Morse MA; Clough RW; Czito BG
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):654-9. PubMed ID: 20864265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer.
    Sato GE; Aizawa R; Nakamura K; Takayama K; Inoue T; Yamasaki T; Kobayashi T; Akamatsu S; Ogawa O; Mizowaki T
    J Radiat Res; 2020 Jul; 61(4):622-628. PubMed ID: 32583860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of external beam radiation and brachytherapy to external beam radiation alone for unresectable extrahepatic cholangiocarcinoma.
    Boothe D; Hopkins Z; Frandsen J; Lloyd S
    J Gastrointest Oncol; 2016 Aug; 7(4):580-7. PubMed ID: 27563448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma.
    Jung DH; Kim MS; Cho CK; Yoo HJ; Jang WI; Seo YS; Paik EK; Kim KB; Han CJ; Kim SB
    Radiat Oncol J; 2014 Sep; 32(3):163-9. PubMed ID: 25324988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients.
    Chen YX; Zeng ZC; Tang ZY; Fan J; Zhou J; Jiang W; Zeng MS; Tan YS
    BMC Cancer; 2010 Sep; 10():492. PubMed ID: 20840777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung.
    Owen D; Olivier KR; Song L; Mayo CS; Miller RC; Nelson K; Bauer H; Brown PD; Park SS; Ma DJ; Garces YI
    Front Oncol; 2014; 4():376. PubMed ID: 25642416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
    Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
    Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer.
    Aizawa R; Takayama K; Nakamura K; Inoue T; Kobayashi T; Akamatsu S; Yamasaki T; Ogawa O; Mizowaki T
    Int J Clin Oncol; 2018 Aug; 23(4):749-756. PubMed ID: 29556917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.
    Nishimura Y; Hosotani R; Shibamoto Y; Kokubo M; Kanamori S; Sasai K; Hiraoka M; Ohshio G; Imamura M; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):39-49. PubMed ID: 9300738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients.
    Haddock MG; Gunderson LL; Nelson H; Cha SS; Devine RM; Dozois RR; Wolff BG
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1267-74. PubMed ID: 11286833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemoradiotherapy of unresectable and recurrent cholangiocarcinoma].
    Horiuchi H; Ureshino M; Yoshimura F; Matono S; Fukumitsu T; Kishimoto Y; Sasahara H; Kubota M; Takada K; Noguchi K; Maruyama Y; Kawahara R; Ishikawa H; Hisaka T; Sakai T; Uchida S; Kinoshita H; Shirouzu K
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1996-8. PubMed ID: 18219877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of conventional doses of chemoradiation for unresectable biliary cancer.
    Crane CH; Macdonald KO; Vauthey JN; Yehuda P; Brown T; Curley S; Wong A; Delclos M; Charnsangavej C; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):969-74. PubMed ID: 12095564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
    Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
    Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
    Wild AT; Hiniker SM; Chang DT; Tran PT; Khashab MA; Limaye MR; Laheru DA; Le DT; Kumar R; Pai JS; Hargens B; Sharabi AB; Shin EJ; Zheng L; Pawlik TM; Wolfgang CL; Koong AC; Herman JM
    J Gastrointest Oncol; 2013 Dec; 4(4):343-51. PubMed ID: 24294505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas.
    Petersen IA; Haddock MG; Donohue JH; Nagorney DM; Grill JP; Sargent DJ; Gunderson LL
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):469-75. PubMed ID: 11872294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.